Skip to main content
Log in

Overview

Cardiovascular Drugs and Therapy is dedicated to the development of cardiovascular drug, device, and cell therapy from bench to bedside. The journals takes a fresh and energetic look at advances in this dynamic field.

    Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focuses on developments that include: hyperlipidemia, diabetes and other cardiometabolic conditions, atherosclerosis, ischemic syndromes, heart failure, cardiomyopathies, valvular heart disease, and arrhythmias. These include mechanisms of action and signaling pathways, their potential for new drug development, novel indications for older drugs, genetic approach to treatment, and new directions in device and cell therapy, interventional and structural heart disease, and cardiac and vascular surgery, as well as their guideline-based utilization in real-world patient populations.
  • Authoritative source for researchers and investigators aiming for breakthrough research as well as cardiologists seeking to best serve their patients.
  • Focuses on developments in treatment of various cardiovascular conditions.
  • Listed in Web of Science and PubMed/Medline among other abstracting and indexing services.
  • International readership: North America, Asia, Europe, Middle East and South America
  • Efficient handling with 18 days between submission and first decision, and 17 days between acceptance and online publication.
  • High usage and wide distribution with a global readership.

Editor-in-Chief
  • Yochai Birnbaum
Impact factor
3.4 (2022)
5 year impact factor
3.8 (2022)
Submission to first decision (median)
8 days
Downloads
529,058 (2023)

Latest articles

Journal updates

  • COVID-19 and impact on peer review

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Journal information

Electronic ISSN
1573-7241
Print ISSN
0920-3206
Abstracted and indexed in
  1. BFI List
  2. BIOSIS
  3. Baidu
  4. Biological Abstracts
  5. CAB Abstracts
  6. CLOCKSS
  7. CNKI
  8. CNPIEC
  9. Chemical Abstracts Service (CAS)
  10. Current Contents/Clinical Medicine
  11. Current Contents/Life Sciences
  12. Dimensions
  13. EBSCO
  14. EMBASE
  15. Google Scholar
  16. Japanese Science and Technology Agency (JST)
  17. Medline
  18. Naver
  19. OCLC WorldCat Discovery Service
  20. Pathway Studio
  21. Portico
  22. ProQuest
  23. Reaxys
  24. SCImago
  25. SCOPUS
  26. Science Citation Index Expanded (SCIE)
  27. Semantic Scholar
  28. TD Net Discovery Service
  29. UGC-CARE List (India)
  30. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Science+Business Media, LLC, part of Springer Nature

Navigation